Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Pediatric Ocular Surface Inflammatory Diseases: Clinical Features and Practice Patterns.
Journal: Cornea
Published: July 06, 2025
Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors.
Journal: Journal for immunotherapy of cancer
Published: March 20, 2025
Shining a Light on Disparities in Medicine: Response.
Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
Published: August 21, 2024
Epithelial Membrane Protein 2 (EMP2) Blockade Attenuates Pathological Neovascularization in Murine Oxygen-Induced Retinopathy.
Journal: Investigative ophthalmology & visual science
Published: July 03, 2024
EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer.
Journal: Cancers
Published: March 04, 2024
Satisfaction of Women Faculty in Academic Medicine.
Journal: Journal of women's health (2002)
Published: December 07, 2023
89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors.
Journal: Molecular cancer therapeutics
Published: July 18, 2023
Neuro-ophthalmic complications of immune checkpoint inhibitor therapy: Current status and future directions.
Journal: Frontiers in ophthalmology
Published: September 15, 2022
Reply to Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis?
Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
Published: May 20, 2022
Epithelial membrane protein 2 (EMP2) regulates hypoxia-induced angiogenesis in the adult retinal pigment epithelial cell lines.
Journal: Scientific reports
Published: March 28, 2022
Last Updated: 09/26/2026